Literature DB >> 762403

The increasing isolation of Serratia species from clinical specimens.

H J Brooks, T J Chambers, S Tabaqchali.   

Abstract

A 14-month survey was undertaken in a diagnostic bacteriology laboratory to determine the incidence of Serratia spp. in routine clinical specimens. Gram-negative organisms with enterobacteria-like colonies were tested by a simple screening procedure. Fifty-eight strains of S. marcescens and two strains of S. liquefaciens were isolated from 59 patients. The strains were usually non-pigmented and exhibited multiple antibiotic resistance. Serotyping and determination of bacteriocine sensitivity patterns revealed that the majority of infections were sporadic, although episodes of cross-infection did occur. S. marcescens was considered to contribute significantly to morbidity and mortality in 53% of patients and appears to be of increasing importance in hospital-acquired infections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762403      PMCID: PMC2130121          DOI: 10.1017/s0022172400025444

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  26 in total

1.  Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study.

Authors:  D G Maki; C G Hennekens; C W Phillips; W V Shaw; J V Bennett
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

2.  Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance.

Authors:  C J Wilkowske; J A Washington; W J Martin; R E Ritts
Journal:  JAMA       Date:  1970-12-21       Impact factor: 56.272

3.  Cross-infection with Serratia marcescens in an intensive-therapy unit.

Authors:  J L Whitby; J N Blair; A Rampling
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

4.  Serratia marcescens in hospital practice.

Authors:  S Tabaqchali; T J Chambers; H J Brooks
Journal:  Lancet       Date:  1977-02-05       Impact factor: 79.321

5.  R factors from Serratia marcescens.

Authors:  R W Hedges; V Rodriguez-Lemoine; N Datta
Journal:  J Gen Microbiol       Date:  1975-01

6.  Serratia marcescens in a general hospital.

Authors:  A P Ball; D McGhie; A M Geddes
Journal:  Q J Med       Date:  1977-01

7.  A comparison of typing methods for Serratia marcescens.

Authors:  B Anderhub; T L Pitt; Y J Erdman; W R Willcox
Journal:  J Hyg (Lond)       Date:  1977-08

8.  Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.

Authors:  R D Meyer; R P Lewis; J Halter; M White
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.

Authors:  W H Traub
Journal:  Appl Microbiol       Date:  1972-05

10.  Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.

Authors:  K E Price; M D DeFuria; T A Pursiano
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

View more
  1 in total

Review 1.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.